Health Dept seeks three new PBRT members The Department of Health and Aged Care is seeking three recruits for the Pharmaceutical Benefits Remuneration Tribunal (PBRT), the body which determines how …

Another consumer division spinoff on the way, this time by Sanofi Pharmaceutical giant Sanofi has portrayed how it imagines spinning off its consumer division and turning the parent, in the …

Bondi Sands mist product has incorrect usage directions, says regulator The Therapeutic Good Administration (TGA) has issued a product defection correction warning consumers to not spray a Bondi Sands sunscreen …

Discount giant’s revenue marginally higher but increased sales costs hit overall result Chemist Warehouse founders are on the receiving end of a bumper dividend totalling $364 million, according to the …

Group share price plummets $1.5bn as dividend halves amid a slow post-pandemic recovery Multinational private hospital operation Ramsay Healthcare was punished by shareholders with a 12.1% drop in its share …

Eli Lilly’s Mounjaro will be on the private scrip market by the end of September Revolutionary new type 2 diabetes drug Mounjaro – which is almost better known for producing …

Share exchange offer leaves J & J with just 9.5% of new consumer health outfit Kenvue Shares of newly-minted consumer health care operation Kenvue shares rose 1.4% in pre-market trading …

But “there definitely will be an impact”; Wesfarmers Health boss Priceline’s strong front-of-store profile offers “opportunities” to take some of the edge off the drop in dispensing income as a …

The August 1968 AJP sounds alarm bells about the “hippy-cult” and the consumption of hallucinogenic drugs It’s August 1968, the so-called “Summer Of Love” has just passed, a new moral …

And Symbion wholesaler arm unlikely to give community pharmacy any price respite 60-day dispensing will benefit large banner groups in the long-term as part of a “natural evolution”, EBOS chief …

Eli Lilly’s Mounjaro would need “substantial price reduction”, says PBAC Mounjaro, the type-2 diabetes medication that the New York Times recently predicted “’could overshadow Ozempic” has been refused funding via …

Hearing before South Australian Employment Tribunal listed for 10 days A case brought against some South Australian Chemist Warehouse franchisees outlets alleging underpayment of Certificate III employees will begin today …